Morgan Stanley files notice for 2,196-share sale

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting a proposed sale of 2,196 shares of Common Stock with an effective date of 06/20/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting a proposed sale of 2,196 shares of Common Stock with an effective date of 06/20/2026. The filing also records a prior sale of 2,808 shares on 06/22/2026 for $190,944.

Insights

Securities Compliance Counsel

Form 144 reports a proposed resale under Rule 144 and documents a recent sale.

The filing lists 2,196 shares of restricted Common Stock to be sold on 06/20/2026, and shows a separate sale of 2,808 shares on 06/22/2026 for $190,944. This is a routine notice required when restricted or control securities are proposed for public resale.

Timing and proceeds treatment are as stated in the excerpt; the filing does not provide further distribution method or purchaser details. Subsequent filings or broker confirmations would show settlement specifics.

Key Figures

Proposed shares to be sold: 2,196 shares Shares sold in past 3 months: 2,808 shares Proceeds recorded for prior sale: $190,944

3 metrics

Proposed shares to be sold 2,196 shares Securities To Be Sold on 06/20/2026

Shares sold in past 3 months 2,808 shares Securities Sold During The Past 3 Months on 06/22/2026

Proceeds recorded for prior sale $190,944 Sale of 2,808 shares on 06/22/2026

Key Terms

Form 144, Restricted Stock, Securities Sold During The Past 3 Months

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Common | 06/20/2026 | Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for BBIO report?

It reports a proposed resale of 2,196 shares of Common Stock on 06/20/2026. The excerpt also records a prior sale of 2,808 shares on 06/22/2026 for $190,944, as disclosed in the filing.

Who is listed as the filer on the BBIO Form 144?

The filing names Morgan Stanley Smith Barney LLC as the filer. The filing shows the firm’s address and indicates the securities involved are restricted Common Stock with the 06/20/2026 date.

How many shares were sold in the past three months per the Form 144?

The document records a sale of 2,808 shares on 06/22/2026. The excerpt shows the sale amount as $190,944 for that transaction, recorded under "Securities Sold During The Past 3 Months."

Does the Form 144 state how proceeds will be used?

No specific use of proceeds is included in the excerpt. The filing lists share counts and sale dates but does not describe destination or use of the sale proceeds.

Are the shares described as restricted or unrestricted in the filing for BBIO?

The excerpt labels the securities to be sold on 06/20/2026 as Restricted Stock. That label appears in the "Securities To Be Sold" line of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 04:02 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001855608
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BRIDGEBIO PHARMA, INC.
SEC File Number	001-38959
Address of Issuer	3160 Porter Drive Suite 250 Palo Alto CALIFORNIA 94304
Phone	(650) 391-9740
Name of Person for Whose Account the Securities are To Be Sold	HANNAH A VALANTINE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2196	150579.72	195861242	06/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2026	Restricted Stock	ISSUER			2196	06/20/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
HANNAH A VALANTINE 3160 Porter Drive Suite 250 Palo Alto CA 94304	Common	06/22/2026	2808	190944.00

144: Remarks and Signature

Remarks
Date of Notice	06/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Hannah A Valantine
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)